نتایج جستجو برای: oral dosing

تعداد نتایج: 277969  

Journal: :Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique 2012
Rolanda Vilenchik Matitiahu Berkovitch Azaria Jossifoff Zvi Ben-Zvi Eran Kozer

OBJECTIVE Ibuprofen is a safe and effective non steroidal anti-inflammatory drug (NSAID). Ibuprofen suppositories are marketed in Europe; but data regarding pharmacokinetics of rectal vs. oral ibuprofen in humans is scarce. The objective of this study is to compare the pharmacokinetics of single-dose rectal vs. oral ibuprofen in healthy adult volunteers. METHODS Ten healthy adult male volunte...

2011
Arun Achar Partha Pratim Chakraborty

Background: Acyclovir, a specific and selective inhibitor of replication of herpesviridae family, has well documented efficacy for speedy rash healing and decreasing pain of herpes zoster. Limited oral bioavailability of acyclovir requires frequent dosing. Valacyclovir is rapidly and almost completely converted to acyclovir in vivo and gives three to fivefold increase in acyclovir bioavailabili...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2000
D R Helton D W Osborne S K Pierson M H Buonarati R A Bethem

Dapsone is a potent anti-inflammatory and antibacterial agent that has been used extensively in the oral treatment of leprosy and dermatitis herpetiformis. This study compared the pharmacokinetic profile of dapsone in rats given a single oral or i.v. 12 mg/kg dose (n = 8/group) or a single dermal application of 12 or 60 mg/kg (n = 12/group) in an aqueous gel application medium containing 10 or ...

2010
Tae H Han Rebecca L Blanchard John Palcza Ashley Martucci Cynthia M Miller-Stein Maria Gutierrez Deborah Panebianco Ronda K Rippley Christopher Lines M Gail Murphy

INTRODUCTION: Telcagepant (MK-0974) is a novel, orally active and selective CGRP receptor antagonist being investigated for acute treatment of migraine. Early clinical data suggested greater than dose proportional increases in exposure following oral administration. The aim of the present studies was to definitively characterize the oral and IV dose proportionality of telcagepant. METHODS: Heal...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2009
Simone I Hoehle Gabriel A Knudsen J Michael Sanders I Glenn Sipes

2,2-Bis(bromomethyl)-1,3-propanediol (BMP) is a brominated flame retardant, previously shown to be a multisite carcinogen in experimental animals. Studies were performed to characterize the dispositional and metabolic fate of BMP after oral or intravenous administration to male Fischer-344 rats. After a single oral administration of [(14)C]BMP (10 or 100 mg/kg) >80% of the low dose and 48% of t...

2014
MEI ZHANG XIAOHUI DI LIN XU JUAN XU YONGGE YANG NAN JIANG LIXUE SONG XUETING XU

The aim of the present study was to investigate the pharmacokinetic and pharmacodynamic characteristics of febuxostat following the administration of single and multiple oral doses under fasting conditions to healthy individuals. Thirty-six healthy subjects were randomly divided into three groups, each containing 12 subjects (six male and six female) as follows: Group A, treated with a single o...

2013
A Brett Hauber Steven Han Jui-Chen Yang Ira Gantz Kaan Tunceli Juan Marcos Gonzalez Kimberly Brodovicz Charles M Alexander Michael Davies Kristy Iglay Qiaoyi Zhang Larry Radican

PURPOSE To quantify willingness-to-pay (WTP) for reducing pill burden and dosing frequency among patients with type 2 diabetes mellitus (T2DM), and to examine the effect of dosing frequency and pill burden on likely medication adherence. PATIENTS AND METHODS Participants were US adults with T2DM on oral antihyperglycemic therapy. Each patient completed an online discrete-choice experiment (DC...

2015
Richard Vickers Neil Robinson Emma Best Roger Echols Glenn Tillotson Mark Wilcox

BACKGROUND Clostridium difficile infection (CDI) is a leading cause of diarrhoea in health care settings with symptoms ranging from mild and self-limiting to life threatening. SMT19969 is a novel, non-absorbable antibiotic currently under development for the treatment of CDI. Here we report the results from a Phase I study. METHODS A double-blind, randomized, placebo-controlled study assessin...

2017
Faouzi Djebbari Nicola Stoner Verna Lavender

BACKGROUND Recent advances in cancer therapeutics have resulted in significantly improved overall survival and progression-free survival for patients. Targeted oral systemic anticancer therapies (SACT) offer a range of treatment approaches that differ from traditional cytotoxic chemotherapy: non-cytotoxic oral SACT target malignant disease continuously, have less broad and more favourable safet...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید